mutLBSgeneDB |
Gene summary for KAT2A |
![]() |
Basic gene Info. | Gene symbol | KAT2A |
Gene name | K(lysine) acetyltransferase 2A | |
Synonyms | GCN5|GCN5L2|PCAF-b|hGCN5 | |
Cytomap | UCSC genome browser: 17q21 | |
Type of gene | protein-coding | |
RefGenes | NM_021078.2, | |
Description | GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 2General control of amino acid synthesis, yeast, homolog-like 2STAF97general control of amino acid synthesis protein 5-like 2histone acetyltransferase GCN5histone acetyltransferase K | |
Modification date | 20141207 | |
dbXrefs | MIM : 602301 | |
HGNC : HGNC | ||
Ensembl : ENSG00000108773 | ||
HPRD : 03807 | ||
Vega : OTTHUMG00000133504 | ||
Protein | UniProt: Q92830 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_KAT2A | |
BioGPS: 2648 | ||
Pathway | NCI Pathway Interaction Database: KAT2A | |
KEGG: KAT2A | ||
REACTOME: KAT2A | ||
Pathway Commons: KAT2A | ||
Context | iHOP: KAT2A | |
ligand binding site mutation search in PubMed: KAT2A | ||
UCL Cancer Institute: KAT2A | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0016578 | histone deubiquitination | 18206972 | GO:0043966 | histone H3 acetylation | 10373431 |
Top |
Ligand binding site mutations for KAT2A |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | L531 | R533H | COAD | 1 | T592 | H593L | COAD | 1 | I576 | T574A | HNSC | 1 | V581 | T582N | UCEC | 1 | Y617 | A618T | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for KAT2A |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | T592 | H593L | 0.34769808 | L531 | R533H | -1.4357633 | Y617 | A618T | -0.87812571 | V581 | T582N | -0.76563682 | I576 | T574A | -0.73213997 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for KAT2A |
![]() |
![]() |
Top |
Top |
Phenotype information for KAT2A |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for KAT2A |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
Nutraceutical | DB01992 | Coenzyme A | Small molecule | ![]() |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ACO | ACETYL COENZYME *A | 1z4r | A | L531 I576 V581 T592 Y617 |
Top |
Conservation information for LBS of KAT2A |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |